APA (7th ed.) Citation

Krishnan, T., Safro, M., Furlanetto, D. M., Gill, S., Solar Vasconcelos, J. P., Stuart, H. C., . . . Loree, J. M. (2024). Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors. Journal of Neuroendocrinology, 36(1), 1. https://doi.org/10.1111/jne.13360

Chicago Style (17th ed.) Citation

Krishnan, Tharani, Maria Safro, Daniel Moreira Furlanetto, Sharlene Gill, Joao Paulo Solar Vasconcelos, Heather C. Stuart, Patrick Martineau, and Jonathan M. Loree. "Clinical Impact of Unsuccessful Subcutaneous Administration of Octreotide LAR Instead of Intramuscular Administration in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors." Journal of Neuroendocrinology 36, no. 1 (2024): 1. https://doi.org/10.1111/jne.13360.

MLA (9th ed.) Citation

Krishnan, Tharani, et al. "Clinical Impact of Unsuccessful Subcutaneous Administration of Octreotide LAR Instead of Intramuscular Administration in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors." Journal of Neuroendocrinology, vol. 36, no. 1, 2024, p. 1, https://doi.org/10.1111/jne.13360.